Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.43 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | ELANE | P08246 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9445272 | 0.81 | ALOX5 (0.59) | ALOX5PTGS2ELANE | |
| SCHEMBL7548989 | 0.80 | ALOX5 (0.51) | ALOX5PTGS2ALDH1A1HPGDALOX15 | |
| SCHEMBL6015487 | 0.78 | ALDH1A1 (0.61) | ALDH1A1HPGDALOX15HSD17B10TDP1 | |
| SCHEMBL12732658 | 0.77 | ALDH1A1 (0.52) | ALDH1A1HPGDALOX15HSD17B10TDP1 | |
| SCHEMBL5166273 | 0.73 | ALDH1A1 (0.55) | ALOX5ALDH1A1HPGDALOX15HSD17B10 | |
| SCHEMBL6719931 | 0.73 | ALOX5 (0.62) | ALOX5PTGS2ALDH1A1HPGDALOX15 | |
| SCHEMBL12732921 | 0.72 | ALDH1A1 (0.53) | ALDH1A1HPGDALOX15HSD17B10TDP1 | |
| SCHEMBL921504 | 0.71 | GABRA1 (0.67) | ALOX5PTGS2ALDH1A1HPGDALOX15 | |
| SCHEMBL23748452 | 0.70 | ALOX5 (0.77) | ALOX5PTGS2ALDH1A1HPGDALOX15 | |
| SCHEMBL5165521 | 0.70 | CYP2D6 (0.61) | ALOX5ALDH1A1HPGDALOX15HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040259958-A1 | Non-halogenated phenoxy and/or benzyloxy substituted phenols, antimicrobial compositions containing the same, and methods of using the same | HARPER DAVID SCOTT (US) | 2004-12-23 | — | — | US | claimed |
| US-20020128323-A1 | Non-halogenated phenoxy and/or benzyloxy substituted phenols, antimicrobial compositions containing the same, and methods of using the same | MCNEIL-PPC, INC | 2002-09-12 | — | — | US | claimed |
| US-20040259958-A1 | Non-halogenated phenoxy and/or benzyloxy substituted phenols, antimicrobial compositions containing the same, and methods of using the same | HARPER DAVID SCOTT (US) | 2004-12-23 | — | — | US | disclosed |
| US-6790868-B2 | REDUCING THE PRESENCE OF MICROORGANISMS ON A SUBSTRATE OR IN A FLUID ENVIRONMENT | WARNER-LAMBERT COMPANY | 2004-09-14 | — | — | US | disclosed |
| US-20020128323-A1 | Non-halogenated phenoxy and/or benzyloxy substituted phenols, antimicrobial compositions containing the same, and methods of using the same | MCNEIL-PPC, INC | 2002-09-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020128323-A1 | Non-halogenated phenoxy and/or benzyloxy substituted phenols, antimicrobial compositions containing the same, and methods of using the same | PAOX, NONO, TYR | ALOX5 1083/4885PTGS2 2544/4885ALDH1A1 3391/4885 |
| US-20040259958-A1 | Non-halogenated phenoxy and/or benzyloxy substituted phenols, antimicrobial compositions containing the same, and methods of using the same | PAOX, NONO, TYR | ALOX5 1083/4885PTGS2 2544/4885ALDH1A1 3391/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.